New treatment could be ‘breakthrough’ for vitiligo

Both King and Desai said the drug seems to be well tolerated. King said he doesn’t know how long people would need to take the drug, but suspects some would be on it long-term, possibly for life.

Details of the cases were published online in late January in a research letter in the journal JAMA Dermatology.

Be the first to comment

Leave a Reply

Your email address will not be published.


*